HomeVVY • AMS
add
Vivoryon Therapeutics NV
Previous close
€1.63
Day range
€1.62 - €1.64
Year range
€1.37 - €2.70
Market cap
49.05M EUR
Avg Volume
65.14K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.76M | -60.00% |
Net income | -2.74M | 59.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.74M | 60.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.84M | -68.33% |
Total assets | 6.42M | -62.22% |
Total liabilities | 3.24M | 7.54% |
Total equity | 3.18M | — |
Shares outstanding | 26.23M | — |
Price to book | 13.58 | — |
Return on assets | -107.55% | — |
Return on capital | -212.23% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.74M | 59.64% |
Cash from operations | -2.25M | 66.20% |
Cash from investing | -2.00K | -100.04% |
Cash from financing | -14.00K | 0.00% |
Net change in cash | -2.26M | -37.63% |
Free cash flow | -1.33M | 63.96% |
About
Founded
1997
Website
Employees
14
